Daiichi Sankyo
Xiaopeng Cai is a Senior Data Scientist with a background in biostatistics and bioinformatics. With experience in leading data science teams at companies such as Daiichi Sankyo, Inc., Precision Xtract, Insight Strategy Advisors, and Analysis Group, Xiaopeng has a strong track record of developing advanced analytics-driven solutions in healthcare. Specializing in clinical trial feasibility assessment, market analytics, payer behavior patterns, physician prescribing propensity, and patient treatment patterns, Xiaopeng is dedicated to optimizing product development and commercial launch strategies.
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.